Has abciximab's ship come in?

Abstract

The ADMIRAL (Abciximab before Direct angioplasty and stenting in Myocardial Infarction Regarding Acute and Long-term follow-up) study is a multicentre, double-blind trial in 300 patients presenting with myocardial infarction. They were randomised to treatment with abciximab or placebo, followed by stenting. Abciximab treatment in diabetic and non-diabetic patients improved outcomes at 30 days and 6 months, with these improvements being related to a higher frequency of normal coronary blood flow at 24 hours and 6 months after intervention.

Keywords

myocardial infarction primary angioplasty anti-platelet agent.

Get full access to this article

View all access options for this article.

References

Simes RJ , Topol EJ , Holmes DR Jr et al. Link between the angiographic substudy and mortality outcomes in a large randomised trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. GUSTO-1 Investigators. Circulation 1995;91:1923-8.

Grines CL , Cox DA , Stone GW et al. Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med 1999; 341:1949-56.

Brener SJ , Barr LA , Burchenal JE et al. Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. ReoPro and Primary PTCA Organization and Randomized Trial (RAPPORT) Investigators . Circulation 1998;98:734-41.

Montalescot G. , Barragan P. , Wittenberg O. et al. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction . N Engl J Med 2001;344:1895-903.

Montalescot G. , Barragan P. , Wittemberg O. et al. Abciximab reduces clinical restenosis in diabetic patients undergoing primary stenting for acute myocardial infarction (The ADMIRAL study). Circulation 2001;104 (suppl):II-386 (Abstract).

Bertrand ME , Rupprecht HJ , Urban P. et al. Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting: the clopidogrel aspirin stent international cooperative study (CLASSICS). Circulation 2000;102:624-9.

Marso SP , Lincoff AM , Ellis SG et al. Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus: results of the EPISTENT (Evaluation of platelet IIb/IIIa inhibitor for stenting trial) diabetic substudy. Circulation 1999;100:2477-84.